Platelet-Rich Plasma (PRP) is an autologous blood product rich in growth factors and bioactive molecules that stimulate cell proliferation, tissue growth, and healing. PRP therapy is minimally invasive and safe, with applications in dermatology, orthopedics, gynecology, and more.

The PRP is prepared using an automated, closed-circuit system that ensures a consistent platelet concentration with minimal contamination by red and white blood cells. This standardization is key in avoiding inflammatory responses and optimizing therapeutic outcomes.

• PRP and HA Synergy: The combination of PRP with HA, facilitated by Regen Lab’s Cellular Matrix device, offers a holistic treatment by addressing multiple etiologic factors of OA, such as inflammation and cartilage degradation.
• Clinical Efficacy: Studies indicate that PRP can significantly reduce pain and improve joint function, with some research showing that PRP combined with HA is more effective than either treatment alone.

The book Standardized Platelet-Rich Plasma for Musculoskeletal Disorders, published by the Biobridge Foundation, delves into the role of platelet-rich plasma (PRP) in treating musculoskeletal conditions, including osteoarthritis and tendinopathies. With insights from leading experts and clinical studies, this comprehensive work highlights the advancements in PRP technology, its therapeutic potential, and the latest research in orthobiologics.